4th Annual In Vivo Cell Engineering & Gene Editing Summit

4th Annual In Vivo Cell Engineering & Gene Editing Summit is organized by Hanson Wade and will be held from Jun 03 - 05, 2025 in Hilton Boston Logan Airport, Boston, Massachusetts, United States of America.

Description:
In vivo engineering, coined as the “holy grail” approach, is set to transform cell and gene therapy. With trailblazers like Myeloid Therapeutics and Interius Biotherapeutics now in the clinic, the field eagerly anticipates groundbreaking data that could reshape treatment accessibility and therapeutic possibilities. Join us at the 4th In Vivo Cell Engineering & Gene Editing Summit, the only forum dedicated to this next frontier of research. Discover breakthroughs in preclinical and IND-enabling studies and dive into clinical data.

Here’s a glimpse of what’s in store for the newly refined 2025 program:

• Strategies to deliver payloads to targets beyond the liver
• Key tactics to minimize off-target toxicities
• Comparative insights on viral vs. non-viral delivery systems
• Guidance on inter-governmental regulatory expectations for this novel approach
• Actionable analysis of first-in-human data to refine your own path to the clinic

This summit unites C-suite leaders, VPs, and Directors from cutting-edge companies like Carisma Therapeutics, Capstan Therapeutics, Editas Medicine, Intellia Therapeutics and more. Don’t miss this unique opportunity to gain critical insights into emerging delivery technologies—including LNPs, LVVs, AAVs and proteinbased approaches—to help you progress your own pipeline from research to IND and beyond.As scientific visions solidify into clinical milestones, join us this June to deepen your expertise in developing next-generation in vivo engineered therapies and advance your own pipeline with precision.